Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 4162  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?

Umare V, Nadkarni A, Nadkar M, Rajadhyksha A, Khadilkar P, Ghosh K, Pradhan V D

Year : 2017| Volume: 63| Issue : 2 | Page no: 92-95

   This article has been cited by
 
1 Dietary Sodium, Potassium, and Sodium to Potassium Ratio in Patients With Systemic Lupus Erythematosus
María Correa-Rodríguez, Sara DelOlmo-Romero, Gabriela Pocovi-Gerardino, José-Luis Callejas-Rubio, Raquel Ríos-Fernández, Norberto Ortego-Centeno, Blanca Rueda-Medina
Biological Research For Nursing. 2022; : 1099800421
[Pubmed]  [Google Scholar] [DOI]
2 Predictors of admission to intensive care unit among systemic lupus erythematosus patients: prospective study
Shimaa Mostafa Abdelwhab, Lobna Ismaeil Kotb, Ghada Sameer, Ghada Dawa
Egyptian Rheumatology and Rehabilitation. 2022; 49(1)
[Pubmed]  [Google Scholar] [DOI]
3 Defining IL-6 levels in healthy individuals: A meta-analysis
Elias A. Said, Iman Al-Reesi, Nawal Al-Shizawi, Sanjay Jaju, Mohammed S. Al-Balushi, Crystal Y. Koh, Ali A. Al-Jabri, Lakshmanan Jeyaseelan
Journal of Medical Virology. 2021; 93(6): 3915
[Pubmed]  [Google Scholar] [DOI]
4 A Review of Anti-C Reactive Protein Antibodies in Systemic Lupus Erythematosus
Patricia Richter, Alexandra Burlui, Ioana Bratoiu, Anca Cardoneanu, Ciprian Rezus, Elena Rezus
Journal of Interdisciplinary Medicine. 2021; 6(2): 60
[Pubmed]  [Google Scholar] [DOI]
5 Coronavirus disease 2019 (COVID-19) and autoimmunity
E. L. Nasonov
Rheumatology Science and Practice. 2021; 59(1): 5
[Pubmed]  [Google Scholar] [DOI]
6 The role of Interleukin 6 inhibitors in therapy of severe COVID-19
E. Nasonov, M. Samsonov
Biomedicine & Pharmacotherapy. 2020; 131: 110698
[Pubmed]  [Google Scholar] [DOI]
7 Rethinking interleukin-6 blockade for treatment of COVID-19
S. Scherger, A. Henao-Martínez, C. Franco-Paredes, L. Shapiro
Medical Hypotheses. 2020; 144: 110053
[Pubmed]  [Google Scholar] [DOI]
8 Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors
E. L. Nasonov
PULMONOLOGIYA. 2020; 30(5): 629
[Pubmed]  [Google Scholar] [DOI]
9 Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes
Ali Çoner, Alp Aydinalp, Haldun Müderrisoglu
Endocrine, Metabolic & Immune Disorders - Drug Targets. 2020; 20(1): 96
[Pubmed]  [Google Scholar] [DOI]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow